Like many other organs for transplant, a heart must be harvested from a brain-dead donor with a healthy, functioning body. During transport, the heart is stored at low temperatures to pause the heartbeat until implantation.
It’s been shown that the OCS has increased the number of transplants accepted by surgeons, as well as led to improved post-transplant outcomes. More acceptable donations will ultimately reduce the pre-implantation waiting period, and the cost of patient care.
The OCS HEART is commercially available in Europe and Australia, but not in the United States.